LORTUSS EX is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Sallus Laboratories, Llc. The primary component is Codeine Phosphate; Guaifenesin; Pseudoephedrine Hydrochloride.
Product ID | 69036-130_ec543c14-8427-4659-bcc0-3cdcd149ba81 |
NDC | 69036-130 |
Product Type | Human Otc Drug |
Proprietary Name | LORTUSS EX |
Generic Name | Codeine Phosphate, Guaifenesin, Pseudoephedrine Hydrochloride |
Dosage Form | Liquid |
Route of Administration | ORAL |
Marketing Start Date | 2014-06-01 |
Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
Application Number | part341 |
Labeler Name | Sallus Laboratories, LLC |
Substance Name | CODEINE PHOSPHATE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE |
Active Ingredient Strength | 10 mg/5mL; mg/5mL; mg/5mL |
DEA Schedule | CV |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 2014-06-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part341 |
Product Type | HUMAN OTC DRUG |
Billing Unit | ML |
Marketing Start Date | 2014-06-01 |
Marketing End Date | 2019-12-31 |
Inactivation Date | 2019-11-27 |
Reactivation Date | 2020-05-13 |
Ingredient | Strength |
---|---|
CODEINE PHOSPHATE | 10 mg/5mL |
SPL SET ID: | 69ee642b-423c-4a68-8c16-cae09d3ef59d |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
69036-130 | LORTUSS | Codeine Phosphate, Guaifenesin, Pseudoephedrine Hydrochloride |
60575-414 | Tricode | Codeine Phosphate, Guaifenesin, Pseudoephedrine Hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LORTUSS 88817798 not registered Live/Pending |
Key Therapeutics, llc 2020-03-02 |
LORTUSS 78149278 2818425 Dead/Cancelled |
KOWA PHARMACEUTICALS AMERICA, INC. 2002-07-31 |
LORTUSS 74276053 not registered Dead/Abandoned |
WHITBY PHARMACEUTICALS, INC. 1992-05-18 |